Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.
about
Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax modelPharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis modelProtection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.Application of population pharmacokinetics for preclinical safety and efficacy studies.
P2860
Pharmacokinetics-pharmacodynamics of gatifloxacin in a lethal murine Bacillus anthracis inhalation infection model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@ast
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@en
type
label
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@ast
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@en
prefLabel
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@ast
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@en
P2093
P2860
P356
P1476
Pharmacokinetics-pharmacodynam ...... is inhalation infection model.
@en
P2093
Alan Forrest
Chistopher M Rubino
George L Drusano
Henry S Heine
Paul G Ambrose
Sujata M Bhavnani
William A Craig
P2860
P304
P356
10.1128/AAC.00251-07
P407
P577
2007-09-17T00:00:00Z